| 1 | AML1-ETO driven acute leukemia:insights into pathogenesis and potential therapeutic approaches显示文摘The AML1-ETO fusion transcription factor is generated by the t(8;21)translocation,which is present in approximately 4%-12% of adult and 12%-30% of pediatric acute myeloid leukemia(AML)patients.Both human and mouse models of AML have demonstrated that AML1-ETO is insufficient for leukemogenesis in the absence of secondary events.In this review,we discuss the pathogenetic insights that have been gained from identifying the various events that can cooperate with AML1-ETO to induce AML in vivo.We also discuss potential therapeutic strategies for t(8;21)positive AML that involve targeting the fusion protein itself,the proteins that bind to it,or the genes that it regulates.Recently published studies suggest that a targeted therapy for t(8;21)positive AML is feasible and may be coming sometime soon. | Megan A.Hatlen Lan Wang Stephen D.Nimer | 2012 | Frontiers of Medicine2012，6，3： | 3 |
您所在的机构暂未开通此部分的功能，请联系管理员